首頁 > 市場調查報告書 > 製藥

婦科治療

市場調查報告書

商品編碼

1469805

全球婦科藥物市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Gynecology Drugs Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年04月01日 | 出版商:

Value Market Research | 英文 174 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球婦科藥物市場需求預計將從 2023 年的 670.6 億美元達到近 1,052 億美元的市場規模，2024-2032 年研究期間複合年成長率為 5.13%。

婦科藥物是用來治療影響女性生殖系統的各種婦科疾病和疾病的藥物。這些藥物可能包括荷爾蒙療法、抗生素、止痛藥和抗發炎藥物等，針對月經失調、更年期症狀、骨盆腔炎、子宮內膜異位症和卵巢囊腫等病症。醫療保健專業人員開出這些藥物來緩解症狀、控制慢性病並改善女性的整體生殖健康和福祉。

市場動態

婦科藥物市場主要由滿足女性特定醫療保健需求的幾個關鍵因素所推動。首先，隨著醫療保健提供者尋求有效的藥物治療來控制症狀和改善患者的治療結果，多囊性卵巢症候群（PCOS）、子宮內膜異位症和子宮肌瘤等婦科疾病的盛行率不斷增加，推動了市場的成長。這些疾病影響全球數百萬女性，通常需要長期藥物管理，進而推動市場成長。其次，藥物開發和研究進展透過引入具有改善的功效、安全性和耐受性的創新療法來促進市場擴張。

製藥公司投資開發新型藥物配方、標靶療法和生物製劑，以滿足婦科護理中未滿足的醫療需求，推動市場成長並增強患者的治療選擇。第三，隨著女性尋求醫療干預措施來解決生育問題、月經不調和更年期症狀，人口結構和生活方式因素的變化，例如延遲分娩、荷爾蒙失衡和生殖健康問題，推動了對婦科藥物的市場需求。此外，人們對女性健康問題的認知不斷增強，以及預防性護理和早期介入的重要性，透過鼓勵定期婦科檢查和堅持治療來刺激市場成長。

此外，製藥公司、醫療保健提供者和患者權益團體之間的策略夥伴關係和合作透過提高意識、改善獲得護理的機會以及促進患者教育和賦權來促進市場擴張。政府措施、醫療保健政策和報銷框架透過為婦科藥物研究、開發和商業化提供資金、監管監督和激勵措施來支持市場成長。然而，日益嚴格的監管審查和定價壓力可能會在未來幾年挑戰市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球婦科藥物市場的各個細分市場進行了包容性評估。婦科藥品產業的成長和趨勢為本研究提供了整體方法。

市場區隔

婦科藥物市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

透過治療學

荷爾蒙治療（雌激素治療、黃體素治療、合併治療、甲狀腺替代治療、副甲狀腺素治療等）
非荷爾蒙治療（抗感染劑、抗腫瘤劑、抗發炎劑等）

按指示

婦科癌症
子宮內膜異位症
女性不孕症
更年期障礙
婦科感染
多囊性卵巢症候群
避孕（節育）
其他

按配銷通路

醫院藥房
零售藥局
網路藥局

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲婦科藥物市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。婦科藥物市場的主要參與者包括艾爾建公司、安進公司、拜耳公司、默克公司、輝瑞公司、禮來公司、羅氏公司、阿斯特捷利康公司。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：婦科藥品公司的競爭格局

婦科用藥市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

公司股份分析
市場集中度
Allergan plc.

公司簡介
公司收入
產品
最近的發展

Amgen Inc.

公司簡介
公司收入
產品
最近的發展

Bayer AG

公司簡介
公司收入
產品
最近的發展

Merck & Co. Inc.

公司簡介
公司收入
產品
最近的發展

Pfizer Inc.

公司簡介
公司收入
產品
最近的發展

Eli Lilly Company

公司簡介
公司收入
產品
最近的發展

F. Hoffmann-La Roche Ltd.

公司簡介
公司收入
產品
最近的發展

AstraZeneca

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR112114170

The global demand for Gynecology Drugs Market is presumed to reach the market size of nearly USD 105.2 Billion by 2032 from USD 67.06 Billion in 2023 with a CAGR of 5.13% under the study period 2024 - 2032.

Gynecology drugs are pharmaceutical medications used in the treatment of various gynecological conditions and disorders affecting the female reproductive system. These drugs may include hormonal therapies, antibiotics, analgesics, and anti-inflammatory agents, among others, targeting conditions such as menstrual disorders, menopause symptoms, pelvic inflammatory disease, endometriosis, and ovarian cysts. Healthcare professionals prescribe these drugs to alleviate symptoms, manage chronic conditions, and improve the overall reproductive health and well-being of women.

MARKET DYNAMICS

The market for gynecology drugs is primarily driven by several key factors that address the specific healthcare needs of women. Firstly, the increasing prevalence of gynecological disorders such as polycystic ovary syndrome (PCOS), endometriosis, and uterine fibroids drives market growth as healthcare providers seek effective pharmaceutical treatments to manage symptoms and improve patient outcomes. These conditions affect millions of women worldwide and often require long-term medication management, fuelling market growth. Secondly, drug development and research advancements contribute to market expansion by introducing innovative therapies with improved efficacy, safety, and tolerability profiles.

Pharmaceutical companies invest in developing novel drug formulations, targeted therapies, and biologics to address unmet medical needs in gynecological care, driving market growth and enhancing patient treatment options. Thirdly, changing demographics and lifestyle factors such as delayed childbirth, hormonal imbalances, and reproductive health issues drive the market demand for gynecology drugs as women seek medical interventions to address fertility concerns, menstrual irregularities, and menopausal symptoms. Additionally, the growing awareness of women's health issues and the importance of preventive care and early intervention stimulate market growth by encouraging regular gynecological screenings and treatment adherence.

Moreover, strategic partnerships and collaborations between pharmaceutical companies, healthcare providers, and patient advocacy groups facilitate market expansion by raising awareness, improving access to care, and promoting patient education and empowerment. Government initiatives, healthcare policies, and reimbursement frameworks support market growth by providing funding, regulatory oversight, and incentives for gynecology drug research, development, and commercialization. However, increasing regulatory scrutiny and pricing pressures may challenge market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of gynecology drugs. The growth and trends of gynecology drugs industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the gynecology drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Therapeutics

Hormonal Therapy (Estrogen Therapy, Progestin Therapy, Combination Therapy, Thyroid Replacement Therapy, Parathyroid Hormone Therapy, And Others)
Non-Hormonal Therapy (Anti-Infective Agents, Anti-Neoplastic Agents, Anti-Inflammatory Agents, And Others)

By Indication

Gynecological Cancers
Endometriosis
Female Infertility
Menopausal Disorder
Gynecology Infections
Polycystic Ovary Syndrome
Contraception (Birth Control)
Others

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Gynecology Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Gynecology Drugs market include Allergan plc., Amgen Inc., Bayer AG, Merck & Co., Inc., Pfizer Inc., Eli Lilly Company, F. Hoffmann-La Roche Ltd., AstraZeneca. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . GYNECOLOGY DRUGS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Therapeutics
- 3.7.2 Market Attractiveness Analysis By Indication
- 3.7.3 Market Attractiveness Analysis By Distribution Channel
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL GYNECOLOGY DRUGS MARKET ANALYSIS BY THERAPEUTICS

5.1 Overview by Therapeutics
5.2 Historical and Forecast Data
5.3 Analysis by Therapeutics
5.4 Hormonal Therapy (Estrogen Therapy, Progestin Therapy, Combination Therapy, Thyroid Replacement Therapy, Parathyroid Hormone Therapy, And Others) Historic and Forecast Sales by Regions

6 . GLOBAL GYNECOLOGY DRUGS MARKET ANALYSIS BY INDICATION

6.1 Overview by Indication
6.2 Historical and Forecast Data
6.3 Analysis by Indication
6.4 Gynecological Cancers Historic and Forecast Sales by Regions
6.5 Endometriosis Historic and Forecast Sales by Regions
6.6 Female Infertility Historic and Forecast Sales by Regions
6.7 Menopausal Disorder Historic and Forecast Sales by Regions
6.8 Gynecology Infections Historic and Forecast Sales by Regions
6.9 Polycystic Ovary Syndrome Historic and Forecast Sales by Regions
6.10. Contraception (Birth Control) Historic and Forecast Sales by Regions
6.11 Others Historic and Forecast Sales by Regions

7 . GLOBAL GYNECOLOGY DRUGS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

7.1 Overview by Distribution Channel
7.2 Historical and Forecast Data
7.3 Analysis by Distribution Channel
7.4 Hospital Pharmacies Historic and Forecast Sales by Regions
7.5 Retail Pharmacies Historic and Forecast Sales by Regions
7.6 Online Pharmacies Historic and Forecast Sales by Regions

8 . GLOBAL GYNECOLOGY DRUGS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE GYNECOLOGY DRUGS COMPANIES

9.1. Gynecology Drugs Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF GYNECOLOGY DRUGS INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Allergan plc.
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Amgen Inc.
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Bayer AG
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Merck & Co. Inc.
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Pfizer Inc.
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Eli Lilly Company
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. F. Hoffmann-La Roche Ltd.
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. AstraZeneca
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers : Impact Analysis
Restraints : Impact Analysis
List of Raw Material
List of Raw Material Manufactures
List of Potential Buyers
Analysis by Therapeutics (USD MN)
Hormonal Therapy (Estrogen Therapy, Progestin Therapy, Combination Therapy, Thyroid Replacement Therapy, Parathyroid Hormone Therapy, And Others) Market Sales by Geography (USD MN)
Analysis Market by Indication (USD MN)
Gynecological Cancers Market Sales by Geography (USD MN)
Endometriosis Market Sales by Geography (USD MN)
Female Infertility Market Sales by Geography (USD MN)
Menopausal Disorder Market Sales by Geography (USD MN)
Gynecology Infections Market Sales by Geography (USD MN)
Polycystic Ovary Syndrome Market Sales by Geography (USD MN)
Contraception (Birth Control) Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Analysis by Distribution Channel (USD MN)
Hospital Pharmacies Market Sales by Geography (USD MN)
Retail Pharmacies Market Sales by Geography (USD MN)
Online Pharmacies Market Sales by Geography (USD MN)
Global Gynecology Drugs Market Sales by Geography (USD MN)
North America Market Analysis (USD MN)
United State Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate by Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Gynecology Drugs Report
Market Research Process
Market Research Methodology
Global Gynecology Drugs Market Size, by Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis by Therapeutics
Market Attractiveness Analysis by Indication
Market Attractiveness Analysis by Distribution Channel
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Market Analysis by Therapeutics (USD MN)
Hormonal Therapy (Estrogen Therapy, Progestin Therapy, Combination Therapy, Thyroid Replacement Therapy, Parathyroid Hormone Therapy, And Others) Market Sales by Geography (USD MN)
Global Market Analysis by Indication (USD MN)
Gynecological Cancers Market Sales by Geography (USD MN)
Endometriosis Market Sales by Geography (USD MN)
Female Infertility Market Sales by Geography (USD MN)
Menopausal Disorder Market Sales by Geography (USD MN)
Gynecology Infections Market Sales by Geography (USD MN)
Polycystic Ovary Syndrome Market Sales by Geography (USD MN)
Contraception (Birth Control) Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Global Market Analysis by Distribution Channel (USD MN)
Hospital Pharmacies Market Sales by Geography (USD MN)
Retail Pharmacies Market Sales by Geography (USD MN)
Online Pharmacies Market Sales by Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis